Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ni Catalyzed Cross Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel nickel-catalyzed direct cross-coupling of aryl fluorosulfates and bromides. Reduces steps, avoids toxic reagents. Reliable pharma intermediate supplier.
Patent CN114874127B details a cost-effective nickel-catalyzed method for difluorocarbonylated indolones, offering significant supply chain and purity advantages.
Patent CN103086850A reveals a novel Ni-catalyzed route for CF2O-containing compounds, offering significant cost reduction in electronic chemical manufacturing and improved scalability.
Novel Ni-catalyzed desulfitative coupling of sulfonyl chlorides offers high yield and broad scope. A cost-effective route for API intermediates and fine chemicals.
Novel Ni-catalyzed method for trifluoroethylation using cheap 2-chloro-1,1,1-trifluoroethane. Mild conditions, high yield, suitable for pharma intermediates.
Novel Ni-catalyzed route for Bilastine intermediate II. High yield, low cost, scalable process replacing Palladium methods for pharmaceutical manufacturing.
Patent CN118754905B reveals nickel catalysis for silane synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Patent CN106146454B details a nickel-catalyzed Negishi coupling method for polyfluorinated biaryls, offering high selectivity and cost-effective manufacturing for fine chemical supply chains.
Patent CN116655529A reveals a nickel-catalyzed route for 3-aryl quinolines, offering mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Novel nickel-catalyzed method offers cost reduction in pharma intermediates manufacturing with scalable one-pot synthesis for high-purity aryl alkenyl sulfoxide.
Patent CN110117237B reveals a mild nickel-catalyzed cyanation method for aromatic nitriles. This technology offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN112724110B details a novel nickel-catalyzed route for VEGFR inhibitor intermediates, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN119462473B details a nickel-catalyzed route for pyrrolidine units, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106187656B enables >99% selective monoarylation under mild conditions, reducing costs and lead times for high-purity fine chemicals.